Edition:
United Kingdom

Adaptimmune Therapeutics PLC (ADAP.OQ)

ADAP.OQ on NASDAQ Stock Exchange Global Select Market

7.03USD
23 Oct 2018
Change (% chg)

$-0.52 (-6.89%)
Prev Close
$7.55
Open
$7.55
Day's High
$7.79
Day's Low
$6.72
Volume
566,782
Avg. Vol
114,203
52-wk High
$14.62
52-wk Low
$6.60

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 9.04 -0.078
Mar '18 8.20 -0.037
FY 2017 Dec '17 4.27 -0.049
Sep '17 27.18 -0.002
Jun '17 3.52 -0.036
Mar '17 2.86 -0.051
FY 2016 Dec '16 8.54 -0.036
Sep '16 2.42 -0.044
Jun '16 0.33 -0.052
Mar '16 2.92 -0.037
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 8 6.22 20.00 0.00 3.46
Quarter Ending Mar-19 4 3.50 7.00 0.00 --
Year Ending Dec-18 8 56.41 73.00 38.00 28.13
Year Ending Dec-19 8 24.75 65.00 0.00 18.34
Earnings (per share)
Quarter Ending Dec-18 6 -0.34 -0.25 -0.50 -0.30
Quarter Ending Mar-19 3 -0.32 -0.28 -0.36 --
Year Ending Dec-18 6 -1.00 -0.68 -1.21 -1.00
Year Ending Dec-19 6 -1.23 -1.02 -1.50 -1.44
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.35 33.64
P/E High - Last 5 Yrs. -- 287.14 45.18
P/E Low - Last 5 Yrs. -- 89.68 23.74
Beta -- 0.93 0.88
Price to Sales (TTM) 44.03 124.53 5.83
Price to Book (MRQ) 3.33 15.28 4.89
Price to Tangible Book (MRQ) 3.35 14.51 6.51
Price to Cash Flow (TTM) -- 70.04 22.92
% Owned Institutions 62.37 14.28 2.14

Dividends

  Company industry sector
Dividend Yield -- 0.33 1.51
Dividend Yield - 5 Year Avg -- 0.24 1.52
Dividend 5 Year Growth Rate -- 2.54 5.41
Payout Ratio(TTM) -- 16.74 43.84

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 973.48 411.24 8.09
Sales (TTM) vs TTM 1 Yr. Ago 48.46 103.59 5.81
Sales - 5 Yr. Growth Rate -- 30.71 9.88
EPS (MRQ) vs Qtr. 1 Yr. Ago 30.20 23.99 23.40
EPS (TTM) vs TTM 1 Yr. Ago -44.84 -- --
EPS - 5 Yr. Growth Rate -- 37.59 10.92
Capital Spending - 5 Yr. Growth Rate -- 38.51 14.87

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.95 2.25
Current Ratio (MRQ) 7.86 5.36 3.05
LT Debt to Equity (MRQ) 0.00 34.91 12.79
Total Debt to Equity (MRQ) 0.00 36.72 17.21
Interest Coverage (TTM) -- -97.07 37.48

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.06 54.86
Gross Margin - 5 Yr. Avg. -- 48.98 52.38
EBITD Margin (TTM) -435.08 -- --
EBITD - 5 Yr. Avg -- -578.76 11.01
Operating Margin (TTM) -457.44 -789.30 4.03
Operating Margin - 5 Yr. Avg. -- -599.86 6.34
Pre-Tax Margin (TTM) -432.60 -751.43 5.08
Pre-Tax Margin - 5 Yr. Avg. -- -605.48 6.78
Net Profit Margin (TTM) -438.00 -752.40 1.35
Net Profit Margin - 5 Yr. Avg. -- -608.15 3.03
Effective Tax Rate (TTM) -- 23.50 23.24
Effective Tax Rate - 5 Yr. Avg. -- 18.68 24.16

Efficiency

  Company industry sector
Revenue/Employee (TTM) 58,154 22,659,931 807,592,034
Net Income/Employee (TTM) -254,715 1,701,937 94,981,854
Receivable Turnover (TTM) 24.65 20.75 5.78
Inventory Turnover (TTM) -- 2.37 3.63
Asset Turnover (TTM) 0.07 0.40 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -28.98 -1.42 10.90
Return on Assets - 5 Yr. Avg. -- 3.03 12.01
Return on Investment (TTM) -32.06 0.18 14.27
Return on Investment - 5 Yr. Avg. -- 2.10 15.60
Return on Equity (TTM) -35.60 1.14 15.99
Return on Equity - 5 Yr. Avg. -- 2.73 16.87
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -- -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Adaptimmune Therapeutics PLC

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -8.62 -11.77 35 58
13 Week 66.87 58.74 99 61
26 Week 43.16 32.28 99 78
52 Week 20.18 1.86 99 47
YTD 101.48 76.94 99 59
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 68.71%
# of Holders: 101
Total Shares Held: 64,868,646
3 Mo. Net Change: 8,571,215
# New Positions: 3
# Closed Positions: 1
# Increased Positions: 7
# Reduced Positions: 7
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.